InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Cini John K., Directeur Scientifique. Insider active across 1 company, notably Sonnet BioTherapeutics Holdings, Inc.. Cumulatively, 7 filings have been published. History available since 25 May 2021. The latest transaction was disclosed on 25 May 2021 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Cini John K.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
14,116 股Common StockSEC:0001493152-25-026064:0
12,000 股Common StockSEC:0001641172-25-019778:0
1,888 股Common StockSEC:0001493152-24-048952:0
18,551 股Common StockSEC:0001493152-23-005465:0
18,551 股Common StockSEC:0001493152-22-036314:0
80,034 股Common StockSEC:0001493152-22-009484:0
14,004 股@ US$1.51100.0% 占其流量Common StockSEC:0001493152-21-013205:0
7 条申报中的 7 条
About Cini John K.
John K. Cini is the Chief Scientific Officer at Sonnet BioTherapeutics Holdings, Inc. He is responsible for leading the company's research and development initiatives. His scientific expertise is crucial for the development of new therapies and solutions in the biotechnology field.
